Javascript must be enabled to continue!
NT-proBNP and the Diagnosis of Heart Failure: A Pooled Analysis of Three European Epidemiological Studies
View through CrossRef
Abstract
Many studies have shown that the B-type natriuretic peptides (BNP and NT-proBNP) are proven diagnostic markers for heart failure due to left ventricular systolic dysfunction. The manner in which they are to be used is still being unravelled; most single centre studies have chosen the best concentration of the peptide on ROC analysis as their cut-point resulting in numerous different values for both BNP and NT-proBNP appearing in the literature. We report a different approach of defining an age and sex corrected abnormal concentration for NT-proBNP, derived from normal individuals within a large sample of 3051 subjects pooled from three European epidemiology studies and applying that to the entire population to detect HF and LVD. Three thousand and fifty one subjects were studied. Of these 10% (305) had significant LVD and 3.1% (94) had HF. The median concentrations of NT-proBNP (IQR) in normals, those with LVD and in heart failure subjects were 20 pg/ml (10.30), 117.3 pg/ml (28.145) and 269.6 pg/ml (54.323), P<0.001, respectively. The area under the ROC curve for NT-proBNP for the detection of ‘heart failure’ was 0.85 and 0.69 for LVD. NT-proBNP was an independent predictor of the presence of HF on multivariate analysis. An abnormal NT-proBNP was defined as being >95th centile for normals, age and sex corrected, and diagnosed HF with a sensitivity of 75% and a negative predictive value of 99%. In an additional analysis in a breathless subgroup of our population, in 30% a raised NT-proBNP concentration could be explained by HF due to LVD, in another 64% the high BNP level was associated with some other structural of functional cardiac abnormality or renal impairment. We were unable to assign a possible cause to the high NT-proBNP values in 5.9% of this breathless subgroup of the population. An abnormal NT-proBNP concentration is an accurate diagnostic test both for the exclusion of HF in the population and in ruling out LVD in breathless subjects. An elevated NT-proBNP merely indicates the presence of ‘cardio-renal distress’ and should prompt referral for further investigation.
Oxford University Press (OUP)
Title: NT-proBNP and the Diagnosis of Heart Failure: A Pooled Analysis of Three European Epidemiological Studies
Description:
Abstract
Many studies have shown that the B-type natriuretic peptides (BNP and NT-proBNP) are proven diagnostic markers for heart failure due to left ventricular systolic dysfunction.
The manner in which they are to be used is still being unravelled; most single centre studies have chosen the best concentration of the peptide on ROC analysis as their cut-point resulting in numerous different values for both BNP and NT-proBNP appearing in the literature.
We report a different approach of defining an age and sex corrected abnormal concentration for NT-proBNP, derived from normal individuals within a large sample of 3051 subjects pooled from three European epidemiology studies and applying that to the entire population to detect HF and LVD.
Three thousand and fifty one subjects were studied.
Of these 10% (305) had significant LVD and 3.
1% (94) had HF.
The median concentrations of NT-proBNP (IQR) in normals, those with LVD and in heart failure subjects were 20 pg/ml (10.
30), 117.
3 pg/ml (28.
145) and 269.
6 pg/ml (54.
323), P<0.
001, respectively.
The area under the ROC curve for NT-proBNP for the detection of ‘heart failure’ was 0.
85 and 0.
69 for LVD.
NT-proBNP was an independent predictor of the presence of HF on multivariate analysis.
An abnormal NT-proBNP was defined as being >95th centile for normals, age and sex corrected, and diagnosed HF with a sensitivity of 75% and a negative predictive value of 99%.
In an additional analysis in a breathless subgroup of our population, in 30% a raised NT-proBNP concentration could be explained by HF due to LVD, in another 64% the high BNP level was associated with some other structural of functional cardiac abnormality or renal impairment.
We were unable to assign a possible cause to the high NT-proBNP values in 5.
9% of this breathless subgroup of the population.
An abnormal NT-proBNP concentration is an accurate diagnostic test both for the exclusion of HF in the population and in ruling out LVD in breathless subjects.
An elevated NT-proBNP merely indicates the presence of ‘cardio-renal distress’ and should prompt referral for further investigation.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
Objectives
The research is to find the related risk factors that may lead to PPCM through analysing and summarising the general clinical characteristics of PPCM p...
Heart failure phenotypes determine NT-proBNP levels in haemodialysis patients independent of volaemia
Heart failure phenotypes determine NT-proBNP levels in haemodialysis patients independent of volaemia
Abstract
Background
Serum N-terminal pro-brain natriuretic peptide (NT-proBNP) is as a widely recognised diagnostic bioma...
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
Objectives
This study was designed to investigate whether admission N-terminal pro-brain natriuretic peptide (NT-proBNP) increase the prognostic accuracy of Globa...
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61
Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61
Abstract
Aim
N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations are lower in patients with obesity. The...
Diagnostic value and risk correlation of serum heart-type fatty acid-binding protein (H-FABP) and osteoprotegerin (OPG) in chronic heart failure
Diagnostic value and risk correlation of serum heart-type fatty acid-binding protein (H-FABP) and osteoprotegerin (OPG) in chronic heart failure
Background: To analyse the value of H-FABP and OPG in determining the severity of heart function in those suffering from long-term heart failure. Methods: A total of 196 patients w...
Characterization and Prediction of Natriuretic Peptide “Nonresponse” During Heart Failure Management: Results From the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT‐proBNP–Assisted Treatment to Lessen Serial Cardiac Readmissions an
Characterization and Prediction of Natriuretic Peptide “Nonresponse” During Heart Failure Management: Results From the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT‐proBNP–Assisted Treatment to Lessen Serial Cardiac Readmissions an
Many proven heart failure (HF) therapies decrease N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) values over time, yet some patients have an NT‐proBNP >1000 pg/mL followi...

